Physician profile
Clive E Robertson
NPI 1710655006
$7,421.33
in general payments reported to CMS, 2019-2025
33 companies · $996 in 2025
The $996 reported for 2025 was more than what 86% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $52.94 · 2022: $2,515 · 2023: $1,559 · 2024: $2,299 · 2025: $996.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,853.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,853.24 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $2,155.86 | 2022-2025 | Wavewriter Alpha Prime 16, General - Pain Management, Superion Indirect Decompression System |
| Abbvie INC. | $1,454.25 | 2022-2025 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $963.38 | 2022-2025 | Relistor, Trulance |
| Collegium Pharmaceutical, INC. | $393.51 | 2022-2024 | Belbuca, Xtampza |
| Janssen Pharmaceuticals, INC | $329.63 | 2021-2025 | Spravato |
| Teva Pharmaceuticals USA, INC. | $260.34 | 2022-2025 | Austedo Xr, Austedo Xr, Ajovy |
| Lundbeck LLC | $219.92 | 2024-2025 | Vyepti |
| Valinor Pharma, LLC | $188.72 | 2023-2025 | Movantik |
| Pfizer INC. | $183.35 | 2023-2025 | |
| Ultragenyx Pharmaceutical INC. | $148.82 | 2022-2023 | |
| Biohaven Pharmaceutical Holding Company LTD. | $134.79 | 2022 | |
| Grt US Holding, INC. | $116.58 | 2022 | |
| Painteq LLC | $112.48 | 2024 | Painteq |
| Ibsa Pharma INC. | $92.76 | 2022-2024 | Tirosint, Licart, Licart |
| Amgen INC. | $85.44 | 2022 |
Show all 33 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Redhill Biopharma INC. | $75.82 | 2022 | |
| Si-Bone, INC. | $55.55 | 2025 | |
| Kyowa Kirin, INC. | $54.68 | 2024 | Crysvita |
| Merz Pharmaceuticals, LLC | $53.17 | 2025 | Xeomin |
| Axsome Therapeutics, INC. | $46.26 | 2025 | Auvelity |
| Pacira Pharmaceuticals Incorporated | $41.31 | 2022-2024 | Iovera, Zilretta |
| Vertex Pharmaceuticals Incorporated | $34.59 | 2025 | |
| Stimwave Technologies Incorporated | $27.10 | 2022 | |
| Spinal Simplicity, LLC | $26.66 | 2025 | Ha Minuteman G3-R |
| Globus Medical, INC. | $25.27 | 2025 | Senza |
| Averitas Pharma INC. | $23.13 | 2023 | Qutenza |
| Relievant Medsystems, INC. | $19.65 | 2023 | Intracept |
| Allergan, INC. | $18.73 | 2022 | |
| Biodelivery Sciences International, INC. | $17.73 | 2021 | |
| Biohaven Pharmaceuticals, INC. | $17.57 | 2021 | |
| Indivior INC. | $16.45 | 2024 | Sublocade |
| Lilly USA, LLC | $14.00 | 2022 | |
| Takeda Pharmaceuticals U.S.A., INC. | $13.83 | 2025 | Trintellix |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Clive Robertson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.